Skip to main

Designation of Andepatuzumab mafodotin (TBA) as an orphan drug - AbbVie Pty Ltd

Administered by
  • Department of Health, Disability and Ageing

This item is authorised by the following title:

Latest version
C2016G0127823 September 2016

Legislation text